Analogues of the canonical nucleosides have a longstanding presence and proven capability within medicinal chemistry and drug discovery research. Herein we report chemical diversification of carbocyclic pyrimidine nucleosides, containing CF2 and CHF in place of furanose oxygen, to introduce ring unsaturation and 2’-epimers. Utilising gram-scale access to 6’-(R)-monofluoro- and 6’-gem-difluorouridine we explore provision of 2’,3’-didehydro-2’,3’-dideoxy and 1’,2’-didehydro-2’-deoxy analogues, alongside the first example of 6’-(R)-fluoroarabino carbauridine. Key stereochemistries and the presence of unsaturation are confirmed using X-ray crystallography and NMR, and an indicative conformational preference for a monofluoro 2’,3’-didehydro-2’,3’-dideoxy system is presented. This synthetic blueprint offers potential to explore biological activity for these hitherto unavailable materials, including for direct comparison to established nucleoside analogue drugs.